Glaukos Corporation Enters into Definitive Agreement to Acquire DOSE Medical Corporation
Early-Stage Bioerodible Sustained-Release Technologies Designed for the Treatment of Retinal Diseases SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic...